CUMBERLAND PHARMACEUTICALS INC CPIX

About CUMBERLAND PHARMACEUTICALS INC (CPIX): stock profile, AI score and financials

CUMBERLAND PHARMACEUTICALS INC (CPIX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CPIX at 20.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,749 of 2,925 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (5.9) and revenue growth (9.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), CUMBERLAND PHARMACEUTICALS INC reports quarterly revenue of $166.5K, net income of $-4.3M, free cash flow of $130.5K. CPIX trades on the Nasdaq exchange and files with the SEC under CIK 1087294. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CPIX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CUMBERLAND PHARMACEUTICALS INC directly from SEC EDGAR.

SEC EDGAR: CIK 1087294 →